[go: up one dir, main page]

WO2013025763A3 - Tissue engineering using injectable, oxidized alginate hydrogels - Google Patents

Tissue engineering using injectable, oxidized alginate hydrogels Download PDF

Info

Publication number
WO2013025763A3
WO2013025763A3 PCT/US2012/050876 US2012050876W WO2013025763A3 WO 2013025763 A3 WO2013025763 A3 WO 2013025763A3 US 2012050876 W US2012050876 W US 2012050876W WO 2013025763 A3 WO2013025763 A3 WO 2013025763A3
Authority
WO
WIPO (PCT)
Prior art keywords
injectable
tissue engineering
alginate hydrogels
oxidized alginate
oxidized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2012/050876
Other languages
French (fr)
Other versions
WO2013025763A2 (en
Inventor
David J. Mooney
Woo Seob KIM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard University
Original Assignee
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard University filed Critical Harvard University
Publication of WO2013025763A2 publication Critical patent/WO2013025763A2/en
Publication of WO2013025763A3 publication Critical patent/WO2013025763A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/74—Alginate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Disclosed herein is a cell implantation pre-matrix composition comprising oxidized high molecular weight alginate and oxidized low molecular weight alginate, for combination with cells and polymerization into a hydrogel. Also disclosed are methods of generating a tissue at a site in a subject by the administration of the hydrogel described herein. The generation of fat tissue in a subject by the methods described herein is envisioned.
PCT/US2012/050876 2011-08-15 2012-08-15 Tissue engineering using injectable, oxidized alginate hydrogels Ceased WO2013025763A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161523506P 2011-08-15 2011-08-15
US61/523,506 2011-08-15
US201161549012P 2011-10-19 2011-10-19
US61/549,012 2011-10-19

Publications (2)

Publication Number Publication Date
WO2013025763A2 WO2013025763A2 (en) 2013-02-21
WO2013025763A3 true WO2013025763A3 (en) 2013-05-10

Family

ID=47715676

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/050876 Ceased WO2013025763A2 (en) 2011-08-15 2012-08-15 Tissue engineering using injectable, oxidized alginate hydrogels

Country Status (1)

Country Link
WO (1) WO2013025763A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2983718A4 (en) 2013-04-11 2016-12-07 Univ Of Vermont And State Agricultural College DECELLULARIZATION AND REZELLULARIZATION OF COMPLETE ORGANS
CN103554300A (en) * 2013-11-20 2014-02-05 青岛明月海藻集团有限公司 Method for preparing high-viscosity oxidized sodium alginate
WO2017165490A1 (en) * 2016-03-22 2017-09-28 President And Fellows Of Harvard College Biocompatible adhesives and methods of use thereof
CA3072340A1 (en) * 2017-08-10 2019-02-14 University Of Massachusetts Human adipose tissue progenitors for autologous cell therapy for lipodystrophy
KR102223043B1 (en) * 2018-09-28 2021-03-08 주식회사 히에라바이오 Mesenchymal stem cells derived from synovium and uses thereof
EP4138863A4 (en) * 2020-06-05 2024-06-19 Duke University Compositions and methods for augmenting autologous fat grafts
WO2022076812A2 (en) 2020-10-09 2022-04-14 University Of Massachusetts Targeting nrip1 to alleviate metabolic disease
CN113181419B (en) * 2021-03-23 2022-08-02 中山大学 Novel composite hydrogel support prepared by 3D biological printing technology and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080085295A1 (en) * 2006-07-14 2008-04-10 Fmc Biopolymer As Hydrogels containing low molecular weight alginates and biostructures made therefrom
EP0927196B1 (en) * 1996-09-19 2008-11-05 The Regents Of The University Of Michigan Polymers containing polysaccharides such as alginates or modified alginates

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0927196B1 (en) * 1996-09-19 2008-11-05 The Regents Of The University Of Michigan Polymers containing polysaccharides such as alginates or modified alginates
US20080085295A1 (en) * 2006-07-14 2008-04-10 Fmc Biopolymer As Hydrogels containing low molecular weight alginates and biostructures made therefrom

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HAO, X. ET AL.: "Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction", CARDIOVASCULAR RESEARCH, vol. 75, 2007, pages 178 - 185 *
KONG, H. J. ET AL.: "Quantifying the relation between adhesion ligand-receptor bond formation and cell phenotype", PNAS, vol. 103, 2006, pages 18534 - 18539 *

Also Published As

Publication number Publication date
WO2013025763A2 (en) 2013-02-21

Similar Documents

Publication Publication Date Title
WO2013025763A3 (en) Tissue engineering using injectable, oxidized alginate hydrogels
EP3444352A3 (en) Production of recombinant vaccine in e. coli by enzymatic conjugation
CA2806464C (en) Regenerative tissue scaffolds
WO2012051173A3 (en) A method for promoting the synthesis of collagen and proteoglycan in chondrocytes
MX2014014337A (en) High-concentration stem cell production method.
BR112013030321A2 (en) vaccine composition, method for preparing the vaccine composition, use of the vaccine composition, method for immunizing a pig, csfv vaccine strain, and use of a cell in cultivating a csfv vaccine strain.
EP2740498A3 (en) Compositions and methods for tissue filling and regeneration
BR112013005764A2 (en) surgical mesh
WO2011087779A3 (en) Cell tissue gel containing collagen and hyaluronan
EP2389925A3 (en) Hydrogel implant with varying degrees of crosslinking
WO2011119831A8 (en) Mechanically competent scaffold for rotator cuff and tendon augmentation
WO2012006426A3 (en) Regulatory polynucleotides and uses thereof
ES2572211T3 (en) Skeletal muscle regeneration using mesenchymal stem cells
SG10201804330YA (en) Engineered high-affinity human t cell receptors
WO2013032623A3 (en) Hydrogel implants with varying degrees of crosslinking
WO2011091420A3 (en) Osteogenic cell delivery matrix
WO2009151907A3 (en) Compositions and methods for using cells to treat heart tissue
WO2011109433A9 (en) Tissue for prosthetic implants and grafts, and methods associated therewith
WO2012006100A3 (en) Methods and compositions for enhancing stem cell mobilization
WO2011121051A3 (en) Preparation created from an in vitro culture of dedifferentiated, non-elicited cells of the argania tree, use thereof for treating skin ageing, inflammation and scarring, and production thereof
HK1200695A1 (en) Optimised subcutaneous therapeutic agents
WO2012095743A3 (en) Adipose -derived mesenchymal stem cells for intralymphatic administration in autoimmune and inflammatory diseases
MX2012007898A (en) Methods of providing weight loss therapy in patients with major depression.
WO2014197798A3 (en) Transplantation device and method of use
WO2012122465A3 (en) Yeast with reduced 2,3-butanediol accumulation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12824059

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12824059

Country of ref document: EP

Kind code of ref document: A2